What are considerations before initiation of anticoagulant prophylaxis for antiphospholipid syndrome (APS)?

Updated: Nov 24, 2020
  • Author: Suneel Movva, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

In deciding whether to initiate anticoagulant prophylaxis for patients with antiphospholipid syndrome (APS), the benefits of these agents must be weighed carefully against their significant risks. Life-long treatment with warfarin (see Treatment) is standard for patients who experience recurrent thrombotic events.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!